Breaking News

Catalent Expands Capabilities at Schorndorf Facility

Continues investment in latest drug delivery technologies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions is expanding its drug development and delivery capabilities with significant investments at its Schorndorf, Germany facility. The expansion includes the addition of R&D and commercial scale fluid bed technology, OptiMelt hot melt extrusion, and elevated cGMP compliance for handling of OEB class 3 customer products. 
 “This expansion follows recent investments in OSDrC OPTIDOSE optimized controlled release dose delivery technology at our Winchester, KY site in the U...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters